Creative Medical receives second WHO name designation for cell therapy Feb 10, 2026 09:00AM
Creative Medical reports positive interim data for chronic back pain therapy Jan 13, 2026 09:15AM
Creative Medical Technology receives regulatory approval for burn pit program Jan 6, 2026 09:15AM
CELZ completes enrollment in FDA-cleared trial for back pain therapy Dec 17, 2025 09:15AM
Creative Medical receives WHO approval for olastrocel drug name Dec 2, 2025 09:15AM


Nov 21, 2025 04:36PM Creative Medical Technology Holdings, Inc (CELZ) files for 2.79M share offering by selling stockholders
Oct 29, 2025 09:01AM Creative Medical Technology Holdings secures $4.2M from warrant exercises
Oct 27, 2025 08:15AM Creative Medical Technology shares shareholder letter on clinical progress
Jul 11, 2025 08:01AM Creative Medical Technology receives patent allowance for heart failure treatment
Mar 20, 2025 07:50AM Creative Medical Technology Holdings, Inc (CELZ) Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
Mar 6, 2025 08:11AM Creative Medical Technology (CELZ) exercises warrants for $3.7M in proceeds
Feb 11, 2025 09:25AM Creative Medical Technology (CELZ) Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program
Feb 5, 2025 08:25AM Creative Medical Technology (CELZ) Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
Jan 30, 2025 09:30AM Creative Medical Technology Holdings, Inc (CELZ) Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT
Nov 13, 2024 09:01AM Creative Medical Technology (CELZ) Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Oct 4, 2024 04:48PM Creative Medical Technology (CELZ) Files $50M Mixed Shelf
Jul 24, 2024 09:03AM Creative Medical Technology (CELZ) Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure
Jul 10, 2024 08:32AM Creative Medical Technology Holdings (CELZ) Issues Corporate Update
Jun 24, 2024 02:07PM Roth/MKM Reiterates Buy Rating on Creative Medical Tech Holdings Inc. (CELZ)